United Therapeutics Corporation (UTHR)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 3,551,000 | 3,380,300 | 2,323,600 | 2,167,200 | 1,864,500 |
| Total current liabilities | US$ in thousands | 804,400 | 343,200 | 305,400 | 323,300 | 463,000 |
| Current ratio | 4.41 | 9.85 | 7.61 | 6.70 | 4.03 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,551,000K ÷ $804,400K
= 4.41
The current ratio of United Therapeutics Corp has been consistently above 1 over the past five years, indicating the company's ability to cover its short-term liabilities with its current assets. The current ratio has shown an increasing trend from 2019 to 2022, reaching a peak of 9.85 in 2022, which suggests a strong liquidity position. However, there was a notable decrease in the current ratio to 4.41 in 2023, which may indicate a potential decrease in short-term liquidity. Overall, the company has maintained a healthy current ratio, providing assurance that it can meet its short-term obligations comfortably.
Peer comparison
Dec 31, 2023